Back

Red-flags for cardiac amyloidosis in real life of an internal medicine department

17 May 2025 (12:33 - 13:26)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease (2) Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Isabel Fiteni Mera

HOSPITAL ROYO VILLANOVA, Zaragoza (Spain)

8 More presentations in this session

Presentation thumbnail
Effects of tafamidis on pacemaker therapy
Doctor M. Figueiredo (Barreiro, PT)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics, mortality outcomes and survival predictors of transthyretin cardiac amyloidosis in an Asian registry
Doctor V. Putri (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
A descriptive journey through the heart of transthyretin cardiac amyloidosis
Doctor M. Rodrigues Simoes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Diagnostic value of the right ventricular wall thickness and free wall strain ratio in distinguishing hypertrophic cardiomyopathy and wild-type transthyretin cardiac amyloidosis
Doctor E. Mata (Creixomil, PT)
Abstract Slides Video
Presentation thumbnail
Associations between age and sex and cardiovascular outcomes in patients with non-obstructive hypertrophic cardiomyopathy
Doctor P. Gebrehiwet (South San Francisco, US)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in myocardial disease (2)

The Event

Event poster

Heart Failure 2025

17 May 2025 12:33 CET
You may be interested in
thumbnail
Congress Presentation
Epidemiology of amyloidosis in heart failure and red flags
thumbnail
Congress Presentation
Investigation of the prevalence of cardiac amyloidosis among patients with echocardiographically verified myocardial hypertrophy of unknown etiology
thumbnail
Congress Presentation
Diagnostic algorithm, red flags, and outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources